Dale Chappell, Chief Scientific Officer, 10% Owner at HUMANIGEN, INC (HGEN), sold 958,243 shares at $19.50 ($18.1M) on 2021-06-16, disclosed to the SEC on 2021-06-21.
Open-market sale of $18.1M HGEN by Chief Scientific Officer, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.40 | 111,325 | $2.2M | 11.9% |
| 2 | $19.40 | 34,431 | $668K | 3.7% |
| 3 | $19.40 | 34,431 | $668K | 3.7% |
| 4 | $19.50 | 12,730 | $248K | 1.4% |
| 5 | $19.17 | 131,532 | $2.5M | 13.9% |
| 6 | $19.17 | 131,532 |
| $2.5M |
| 13.9% |
| 7 | $19.17 | 36,284 | $696K | 3.8% |
| 8 | $19.17 | 13,607 | $261K | 1.4% |
| 9 | $19.17 | 13,607 | $261K | 1.4% |
| 10 | $19.17 | 36,284 | $696K | 3.8% |
| 11 | $18.50 | 30,186 | $558K | 3.1% |
| 12 | $18.50 | 80,496 | $1.5M | 8.2% |
| 13 | $18.50 | 291,798 | $5.4M | 29.7% |
| Total | $18.94 avg | 958,243 | $18.1M | 100% |
| Filing → |
| HGEN | SELL | 2021-06-25 | $27.8M | — | Filing → |
| MRFD | SELL | 2011-03-21 | $12K | — | Filing → |
| MRFD | SELL | 2011-03-14 | $21K | — | Filing → |